Crossmark

Machine learning-based identification of high-risk triple-negative breast cancer patients despite pathological complete response after neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1038/s41523-026-00979-0

Published Online: 2026-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kwakkenbos, Koen

van den Ende, Nadine S.

Heemskerk-Gerritsen, Bernadette A. M.

Veenland, Jifke F.

Jager, Agnes

van Deurzen, Carolien H. M.
Funding

Funding for this research was provided by:

Hanarth Fonds
License Information

Text and Data Mining valid from 2026-06-02

Accepted Manuscript valid from 2026-06-02
More Information

Article History

Received: 1 December 2025

Accepted: 24 May 2026

First Online: 2 June 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below